about
Standardised formal resuscitation training programmes for reducing mortality and morbidity in newborn infantsPentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonatesProstaglandin E 1 for maintaining ductal patency in neonates with ductus-dependent cardiac lesionsOral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsMolecular assays for the diagnosis of sepsis in neonatesVideolaryngoscopy versus direct laryngoscopy for tracheal intubation in neonatesVitamin D supplementation for prevention of vitamin D deficiency in preterm and low birth weight infantsVasopressin and its analogues for the treatment of refractory hypotension in neonatesVideolaryngoscopy versus direct laryngoscopy for tracheal intubation in neonatesVasopressin and its analogues for the treatment of refractory hypotension in neonatesFormal resuscitation training courses for reducing mortality and morbidity in newborn infantsPatient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal unitsOral immunoglobulin for the prevention of rotavirus infection in low birth weight infantsOral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsOral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonatesGranulocyte transfusions for neonates with confirmed or suspected sepsis and neutropeniaOral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infantsOral immunoglobulin for the treatment of rotavirus diarrhea in low birth weight infantsPentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonatesOral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonatesPatient isolation measures for infants with candida colonization or infection for preventing or reducing transmission of candida in neonatal unitsGranulocyte transfusions for neonates with confirmed or suspected sepsis and neutropaeniaPentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates
P50
Q24187320-78A61B65-2230-48B0-AB31-8EE2B36C37EAQ24187349-85213DE6-C723-47E1-82DD-D1785827CCFFQ24187669-145366E6-F43C-43F1-AC26-7524062AD482Q24188043-0069DE0F-A752-415B-929B-A305F7CD1E9AQ24188061-C26DB53F-87D0-40AA-92DD-742659CE7740Q24188107-4861A97A-1B88-4535-8A10-E577AA2A5893Q24188292-7BE920D0-DF5D-4210-93BE-28978AC7F37DQ24200218-1E7B7425-639D-4524-BA5C-9C91A57D7524Q24202345-3D13EAC1-29B7-4711-B570-B2817516C4BCQ24233995-92FF8D12-DBDF-42A0-894E-FE6F1E209E07Q24234727-E7BEF9CF-CB45-4F7B-A273-78C6FEE0ED5CQ24235328-319610A1-6C36-4048-8C32-D0B666171EFBQ24235408-615901E5-12CC-45A6-A436-F47232278416Q24235455-F27EF152-8320-419B-93EA-435EA9D5805FQ24235911-462EA661-67D8-4125-88EF-E977027CA5FEQ24236008-6CDB27D4-7E5B-4B30-955A-554B68D3235DQ24236014-BF0F0984-3ED0-41E4-BB1F-07641368CC8AQ24236023-A5FDF182-19A8-427C-89F2-1AE1ACF08F83Q24236202-079D56BF-0074-45AC-B211-20BCA24DFC59Q24241292-CD5ABB95-222B-4853-B75E-471727A73D89Q24243803-1C1837E8-A511-406D-A820-88BA419E277AQ24247663-AD73B10F-8F08-40F9-812B-A82A3D8FB558Q24248766-AB26CE1E-DB7B-44EB-A7A3-506C51E44AEE
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mohan Pammi
@ast
Mohan Pammi
@en
Mohan Pammi
@es
Mohan Pammi
@nl
Mohan Pammi
@sl
type
label
Mohan Pammi
@ast
Mohan Pammi
@en
Mohan Pammi
@es
Mohan Pammi
@nl
Mohan Pammi
@sl
prefLabel
Mohan Pammi
@ast
Mohan Pammi
@en
Mohan Pammi
@es
Mohan Pammi
@nl
Mohan Pammi
@sl